JP2020189843A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020189843A5 JP2020189843A5 JP2020123616A JP2020123616A JP2020189843A5 JP 2020189843 A5 JP2020189843 A5 JP 2020189843A5 JP 2020123616 A JP2020123616 A JP 2020123616A JP 2020123616 A JP2020123616 A JP 2020123616A JP 2020189843 A5 JP2020189843 A5 JP 2020189843A5
- Authority
- JP
- Japan
- Prior art keywords
- acetaminophen
- amino acid
- acid sequence
- seq
- protein adduct
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims 24
- 125000003275 alpha amino acid group Chemical group 0.000 claims 12
- 229960005489 paracetamol Drugs 0.000 claims 12
- 238000000034 method Methods 0.000 claims 10
- 239000012472 biological sample Substances 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 239000000523 sample Substances 0.000 claims 4
- 230000001988 toxicity Effects 0.000 claims 4
- 231100000419 toxicity Toxicity 0.000 claims 4
- 210000004369 blood Anatomy 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 210000004209 hair Anatomy 0.000 claims 2
- 238000003018 immunoassay Methods 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 210000002381 plasma Anatomy 0.000 claims 2
- 210000003296 saliva Anatomy 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- 210000002700 urine Anatomy 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462086923P | 2014-12-03 | 2014-12-03 | |
| US62/086,923 | 2014-12-03 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017548368A Division JP6785239B2 (ja) | 2014-12-03 | 2015-12-03 | 抗アセトアミノフェン抗体及びアセトアミノフェンタンパク質付加物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020189843A JP2020189843A (ja) | 2020-11-26 |
| JP2020189843A5 true JP2020189843A5 (enExample) | 2021-04-01 |
| JP7072022B2 JP7072022B2 (ja) | 2022-05-19 |
Family
ID=56092671
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017548368A Active JP6785239B2 (ja) | 2014-12-03 | 2015-12-03 | 抗アセトアミノフェン抗体及びアセトアミノフェンタンパク質付加物 |
| JP2020123616A Active JP7072022B2 (ja) | 2014-12-03 | 2020-07-20 | 抗アセトアミノフェン抗体及びアセトアミノフェンタンパク質付加物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017548368A Active JP6785239B2 (ja) | 2014-12-03 | 2015-12-03 | 抗アセトアミノフェン抗体及びアセトアミノフェンタンパク質付加物 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10570216B2 (enExample) |
| EP (1) | EP3227681B1 (enExample) |
| JP (2) | JP6785239B2 (enExample) |
| AU (2) | AU2015358373B2 (enExample) |
| CA (1) | CA2967037A1 (enExample) |
| ES (1) | ES2841904T3 (enExample) |
| WO (1) | WO2016090163A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015123574A1 (en) | 2014-02-14 | 2015-08-20 | The Board Of Trustees Of The University Of Arkansas | Acetaminophen protein adducts and methods of use thereof |
| CA2967037A1 (en) | 2014-12-03 | 2016-06-09 | Bioventures, Llc | Anti-acetaminophen antibodies and acetaminophen protein adducts |
| CN112980808B (zh) * | 2019-12-12 | 2024-10-29 | 深圳迈瑞生物医疗电子股份有限公司 | 尿酸酶、及其制备方法和用途 |
| CN113248596B (zh) * | 2021-04-15 | 2022-12-16 | 华南农业大学 | 一种可同时检测对乙酰氨基酚和非那西丁的人工抗原、抗体及其制备方法和应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5103021A (en) | 1982-04-02 | 1992-04-07 | Syntex (U.S.A.) Inc. | Acetaminophen analogs, antigens, and antibodies |
| US4424150A (en) | 1982-04-02 | 1984-01-03 | Syva Company | Acetaminophen analogs, antigens, and antibodies |
| ES2150428T3 (es) | 1987-04-27 | 2000-12-01 | Unilever Nv | Ensayos de union especifica. |
| US6352862B1 (en) | 1989-02-17 | 2002-03-05 | Unilever Patent Holdings B.V. | Analytical test device for imuno assays and methods of using same |
| ES2181734T3 (es) | 1990-11-20 | 2003-03-01 | Dade Behring Marburg Gmbh | Ensayo inmunologico de ciclosporina. |
| US6905882B2 (en) | 1992-05-21 | 2005-06-14 | Biosite, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
| US5747352A (en) | 1994-05-23 | 1998-05-05 | Beckman Instruments, Inc. | Reagents and methods for the rapid and quantitative assay of pharmacological agents |
| US5620890A (en) * | 1995-03-14 | 1997-04-15 | The United States Of America As Represented By The Secretary Of Agriculture | Monoclonal antibodies to hygromycin B and the method of making the same |
| US20040185040A1 (en) * | 2001-11-21 | 2004-09-23 | Celltech R & D Limited | Modulating immune responses |
| WO2009097133A2 (en) * | 2008-01-30 | 2009-08-06 | Monsanto Technology, Llc | Transgenic plants with enhanced agronomic traits |
| WO2009099580A2 (en) | 2008-02-05 | 2009-08-13 | Monsanto Technology, Llc | Isolated novel nucleic acid and protein molecules from soy and methods of using those molecules to generate transgenic plants with enhanced agronomic traits |
| US20090263839A1 (en) | 2008-04-21 | 2009-10-22 | Board Of Trustees Of The University Of Arkansas | Acetaminophen-protein adduct assay device and method |
| US9012723B2 (en) * | 2009-01-16 | 2015-04-21 | Monsanto Technology Llc | Isolated novel acid and protein molecules from soy and methods of using those molecules to generate transgene plants with enhanced agronomic traits |
| SG178348A1 (en) | 2009-08-19 | 2012-03-29 | Merck Patent Gmbh | Antibodies for the detection of integrin complexes in ffpe material |
| DK2993183T3 (da) * | 2010-02-16 | 2020-03-30 | Oesterreichische Akademie Der Wss | Anti-hpv e7-antistoffer |
| US20110214205A1 (en) | 2010-02-26 | 2011-09-01 | Monsanto Technology Llc. | Isolated Novel Nucleic Acid and Protein Molecules from Foxtail Millet and Methods of Using Those Molecules to Generate Transgenic Plants with Enhanced Agronomic Traits |
| CN103688176A (zh) | 2011-04-29 | 2014-03-26 | 细胞基因公司 | 利用cereblon作为预报因子治疗癌和炎性疾病的方法 |
| EP2841575B1 (en) * | 2012-04-27 | 2019-06-26 | Millennium Pharmaceuticals, Inc. | Anti-gcc antibody molecules and use of same to test for susceptibility to gcc-targeted therapy |
| WO2015123574A1 (en) | 2014-02-14 | 2015-08-20 | The Board Of Trustees Of The University Of Arkansas | Acetaminophen protein adducts and methods of use thereof |
| CA2967037A1 (en) | 2014-12-03 | 2016-06-09 | Bioventures, Llc | Anti-acetaminophen antibodies and acetaminophen protein adducts |
-
2015
- 2015-12-03 CA CA2967037A patent/CA2967037A1/en active Pending
- 2015-12-03 JP JP2017548368A patent/JP6785239B2/ja active Active
- 2015-12-03 AU AU2015358373A patent/AU2015358373B2/en active Active
- 2015-12-03 WO PCT/US2015/063786 patent/WO2016090163A2/en not_active Ceased
- 2015-12-03 ES ES15865732T patent/ES2841904T3/es active Active
- 2015-12-03 US US15/532,418 patent/US10570216B2/en active Active
- 2015-12-03 EP EP15865732.0A patent/EP3227681B1/en active Active
-
2020
- 2020-01-10 US US16/740,030 patent/US11566081B2/en active Active
- 2020-07-20 JP JP2020123616A patent/JP7072022B2/ja active Active
-
2021
- 2021-08-11 AU AU2021215156A patent/AU2021215156A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7235256B2 (ja) | 重症熱性血小板減少症候群ウイルスの外膜糖タンパク質に結合する抗体及びその用途 | |
| JP2020189843A5 (enExample) | ||
| JP2022115986A5 (enExample) | ||
| JP2020516603A5 (enExample) | ||
| CN113549148B (zh) | Hcv核心脂质结合结构域单克隆抗体 | |
| Goodchild et al. | Isolation and characterisation of Ebolavirus-specific recombinant antibody fragments from murine and shark immune libraries | |
| FI3718564T3 (fi) | Uusia anti-IL 13 -vasta-aineita ja niiden käyttöjä | |
| JP2010539162A5 (enExample) | ||
| JP2010526880A5 (enExample) | ||
| RU2011121818A (ru) | Способ иммунологического анализа белка cxcl1 человека | |
| JP2018527895A5 (enExample) | ||
| JP2020510409A5 (enExample) | ||
| CN112500481B (zh) | 一种人源抗新型冠状病毒的中和活性单克隆抗体 | |
| CN118515763B (zh) | Il-6的抗体、检测试剂盒及其应用 | |
| Prajapati et al. | Bioreceptors for antigen–antibody interactions | |
| RU2019110953A (ru) | Моноклональное антитело, специфически связывающееся с тиоредоксином-1, и его применение | |
| JP2017538786A5 (enExample) | ||
| Davern et al. | Immunodiagnostic capabilities of anti–free immunoglobulin light chain monoclonal antibodies | |
| US9995747B2 (en) | Specific monoclonal antibodies of the antigen M of the human metapneumovirus (HMPV) and use thereof in a diagnostic method | |
| CN118359710B (zh) | 结合冠状病毒SARS-CoV-2和SARS-CoV刺突蛋白RBD的中和抗体ZJ-2及其应用 | |
| JP2019508684A (ja) | 活動性結核の診断のための方法及びキット | |
| JP2023536737A (ja) | Ｓａｒｓ－ｃｏｖ－２を検出するためのアッセイ | |
| CN116143929B (zh) | 抗重组人凝血因子VIIa-Fc融合蛋白的抗体及其应用 | |
| JPWO2019167874A5 (enExample) | ||
| JPWO2023085320A5 (enExample) |